Trials / Sponsors / Kangpu Biopharmaceuticals, Ltd.
Kangpu Biopharmaceuticals, Ltd.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects Hematological Malignancies | Phase 1 | 2021-09-13 |
| Completed | Phase 1b/2a Study to Evaluate Safety and Efficacy of KPG-818 in SLE SLE; Drug | Phase 1 / Phase 2 | 2021-06-03 |
| Completed | Evaluation of Safety and Efficacy of KPG-121 Plus Enzalutamide, Abiraterone or Apalutamide in CRPC Patients Castration-Resistant Prostate Cancer | Phase 1 | 2019-11-26 |
| Completed | Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy Subjects Systemic Lupus Erythematosus | Phase 1 | 2019-05-01 |